GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Other Operating Expense

Pharmarise Holdings (TSE:2796) Other Operating Expense : 円7,533 Mil (TTM As of May. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Other Operating Expense?

Pharmarise Holdings's Other Operating Expense for the three months ended in May. 2024 was 円1,941 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in May. 2024 was 円7,533 Mil.

Pharmarise Holdings's quarterly Other Operating Expense increased from Nov. 2023 (円1,761 Mil) to Feb. 2024 (円2,032 Mil) but then declined from Feb. 2024 (円2,032 Mil) to May. 2024 (円1,941 Mil).

Pharmarise Holdings's annual Other Operating Expense increased from May. 2022 (円6,596 Mil) to May. 2023 (円6,695 Mil) and increased from May. 2023 (円6,695 Mil) to May. 2024 (円7,533 Mil).


Pharmarise Holdings Other Operating Expense Historical Data

The historical data trend for Pharmarise Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Other Operating Expense Chart

Pharmarise Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,402.00 6,821.00 6,596.00 6,695.00 7,533.00

Pharmarise Holdings Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,579.00 1,799.00 1,761.00 2,032.00 1,941.00

Pharmarise Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7,533 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmarise Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings Headlines

No Headlines